SIG-009 (Sigilon)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameSIG-009 (Sigilon)
Drug Alias NameF7-transduced allogenic human epithelial cell therapy (Sigilon)
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionCoagulation factor VII stimulants
TargetsCoagulation factor VII
Therapy Area/IndicationsFactor VII Deficiency
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSigilon Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSigilon Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsFactor VII Deficiency

Other Information

ATC CodeN/A
Related LinksN/A